Hostname: page-component-cb9f654ff-9knnw Total loading time: 0 Render date: 2025-08-03T18:00:07.354Z Has data issue: false hasContentIssue false
  • English
  • Français

Infectivity of Hepatitis C Virus in Plasma After Drying and Storing at Room Temperature

Published online by Cambridge University Press:  02 January 2015

Saleem Kamili ,
Kris Krawczynski ,
Karen McCaustland ,
Xiaofang Li  and
Miriam J. Alter
Saleem Kamili*
Affiliation:
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia
Kris Krawczynski
Affiliation:
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia
Karen McCaustland
Affiliation:
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia
Xiaofang Li
Affiliation:
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia
Miriam J. Alter
Affiliation:
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston
*
Division of Viral Hepatitis, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Mail Stop A33, Atlanta, GA 30333 (skamili@cdc.gov)
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To determine effect of environmental exposure on the survival and infectivity of hepatitis C virus (HCV).

Methods.

Three aliquots of chimpanzee plasma containing HCV and proven infectious HCV inoculum were dried and stored at room temperature, 1 aliquot for 16 hours, 1 for 4 days, and 1 for 7 days. A chimpanzee (CH247) was sequentially inoculated intravenously with each of these experimental inocula, beginning with the material stored for 7 days. Each inoculation was separated by at least 18 weeks of follow-up to monitor for infection. The concentration of HCV RNA was measured and quasi species were sequenced for each experimental inoculum and in serum samples from CH247.

Results.

Evidence of HCV infection developed in CH247 only after inoculation with the material stored for 16 hours. No infection occurred after inoculation with the material stored for 7 days or 4 days. Compared with the original infectious chimpanzee plasma, the concentration of HCV RNA was 1 log lower in all 3 experimental inocula. The same predominant sequences were found in similar proportions in the original chimpanzee plasma and in the experimental inocula, as well as in serum samples from CH247.

Conclusion.

HCV in plasma can survive drying and environmental exposure to room temperature for at least 16 hours, which supports the results of recent epidemiologic investigations that implicated blood-contaminated inanimate surfaces, objects, and/or devices as reservoirs for patient-to-patient transmission of HCV. Healthcare professionals in all settings should review their aseptic techniques and infection control practices to ensure that they are being performed in a manner that prevents cross-contamination from such reservoirs.

Information

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 5 , May 2007 , pp. 519 - 524
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1. Alter, MJ. Prevention of spread of hepatitis C. Hematology 2002;36(5 suppl 1):S93–S98.Google Scholar
2. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998;47(RR-19):1–39.Google Scholar
3. Busch, MP, Wilber, JC, Johnson, P, Tobler, L, Evans, CS. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 1992;32:420–425.Google Scholar
4. Hagan, H, Thiede, H, Weiss, NS, Hopkins, SG, Duchin, JS, Alexander, ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001;91:42–46.Google Scholar
5. Williams, IT, Perz, JF, Bell, BP. Viral hepatitis transmission in ambulatory health care settings. Clin Infect Dis 2004;38:1592–1598.CrossRefGoogle ScholarPubMed
6. Bond, WW, Favero, MS, Petersen, NJ, Gravelle, CR, Ebert, JW, Maynard, JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981;1:550–551.CrossRefGoogle ScholarPubMed
7. Carducci, A, Verani, M, Casini, B, et al. Detection and potential indicators of the presence of hepatitis C virus on surfaces in hospital settings. Lett Appi Microbiol 2002;34:189–193.CrossRefGoogle ScholarPubMed
8. Bradley, DW, Krawczynski, K, Ebert, JW, et al. Parenterally transmitted non-A, non-B hepatitis: virus-specific antibody response patterns in hepatitis ? virus-infected chimpanzees. Gastroenterology 1990;99:1054–1060.CrossRefGoogle ScholarPubMed
9. Krawczynski, K, Beach, MJ, Bradley, DW, et al. Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification. Gastroenterology 1992;103:622–629.Google Scholar
10. Krawczynski, K, Alter, MJ, Tankersley, DL, et al. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J Infect Dis 1996;173:822–828.Google Scholar
11. Centers for Disease Control and Prevention. Transmission of hepatitis A and C viruses in outpatient settings-New York, Oklahoma, and Nebraska, 2000-2002. MMWR Morb Mortal Wkly Rep 2003;52:901–906.Google Scholar
12. Comstock, RD, Mallonee, S, Fox, JL, et al. A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol 2004;25:576–583.Google Scholar
13. Macedo de Oliveira, A, White, KL, Leschinsky, DP, et al. An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic. Ann Intern Med 2005;142:898–902.CrossRefGoogle Scholar
14. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Morb Mortal Wkly Rep 2001;50(RR-5):1–43.Google Scholar
15. Hahn, JA, Page-Shafer, K, Lum, PJ, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002;186:1558–1564.CrossRefGoogle ScholarPubMed
16. Des Jarlais, DC, Diaz, T, Perlis, T, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol 2003;157:467–471.CrossRefGoogle ScholarPubMed
17. Samandari, T, Malakmadze, N, Baiter, S, et al. A large outbreak of hepatitis B virus infections associated with frequent injections at a physician's office, Infect Control Hosp Epidemiol 2005;26:745–750.Google Scholar
18. Gilbert, N, Corden, S, Ijaz, S, Grant, PR, Tedder, RS, Boxall, EH. Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differences. J Virol Methods 2002;100:37–47.Google Scholar
19. Favero, MS, Bond, WW, Petersen, NJ, Berquist, KR, Maynard, JE. Detection methods for study of the stability of hepatitis B antigen on surfaces. J Infect Dis 1974;129:210–212.CrossRefGoogle ScholarPubMed
20. Nordenfeit, E, Dahlquist, E. HBsAg positive adopted children as a cause of intrafamilial spread of hepatitis B. Scand J Infect Dis 1978;10:161–163.Google Scholar
21. Petersen, NJ, Barrett, DH, Bond, WW, et al. Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appi Environ Microbiol 1976;32:572–574.Google Scholar